December 2011

Dear Colleagues:

As the year of 2011 comes close to an end, we will remind everyone that Fellowship 2012 application dead-line is January 16, 2012. The application guidelines can be found in Spanish, English, Japanese and Chinese on IASLC website If someone needs help with the application, the IASLC Office is happy to help. Please contact,

We will remind everyone to take care of the IASLC membership fee for 2012 – still US$ 200 per year and US$ 50 for members from developing countries.

Several IASLC meetings are coming up – Please pay attention to and plan for the upcoming meetings of the AACR: Molecular Biology of Lung Cancer in San Diego, CA, January 2012 and the European Lung Cancer Conference (ELCC) with ESMO in Geneva, April 2012 as well as the Latin American Lung Cancer Conference in Rio de Janeiro in July 2012.

Several important strategic decisions will be made by the IASLC Board of Directors in the New Year. Implementation of the strategic plan will have the highest priority and important decisions such as the future of the World Conferences (annual versus bi-annual) will be made based on ongoing exploratory work by an assigned task force.
The IASLC Board of Directors and Executive Office wish all the IASLC members and their families a Happy Holiday and a healthy and successful year 2012.

Fred R. Hirsch, MD, PhD
Editor, IASLC Newsletter


IASLC Fellowship/Young Investigator Announcement/ IASLC/Prevent Cancer Foundation Fellowship Award 2012

IASLC Lung Cancer Fellowship Award
2 years duration

IASLC Young Investigators Award
2 years duration

IASLC/PCF Prevent Cancer Foundation Fellowship Award
2 years duration

The International Association for the Study of Lung Cancer is proud to announce the annual IASLC Fellowship and Young Investigators Programs.

Applications are now requested for the 2012 – 2013 Fellowship and Young Investigator award cycle. Overall, there will be a minimum of three awards of $40,000 per year, each for a duration of two years (total $80,000 per grant), with at least one recipient from each region (North America, Europe and Rest of the World) funded. The Prevent Cancer Foundation (PCF) will jointly sponsor awards focused on lung cancer prevention and translational research, supported through educational grants from Eli Lilly. Additional unrestricted awards in any field of lung cancer research are supported by educational grants from Amgen, Genentech, Celgene, Merck KGaA, Eli Lilly, the IASLC and other sponsors.

The goal is to reward scientific excellence and to encourage innovative research in lung cancer prevention and translational medicine. Applications will be evaluated by a Scientific Review Panel for their merit, innovation and potential impact on the management of lung cancer. The deadline for submission is January 16, 2012. A decision on applications will be reached by March 2012.

Application forms can be found at the website:

Please e-mail you application to: no later than January 16, 2012.

Please remember to pay the IASLC membership fee 2012 - $200

Registering online is fast and easy! Visit for more information.
IASLC members will be sent renewal reminders and invoices. Register now so there will no interruption to your JTO subscription, and to receive discounts on 2012 meeting fees. Please contact the Membership Department if you need any assistance paying your dues:, or call +1.303.724.3159.

FREE IASLC Membership for Fellows:

Did you know that IASLC offers a FREE membership for fellows? This complimentary membership includes online access to the JTO, as well as additional discounts and educational programs. It is a great way to expose clinical fellows to the benefits of IASLC membership and introduce them to IASLC activities. The complimentary Fellow membership is available for a maximum of two years, and requires a verification letter from the program director stating the term dates of the fellowship. Please forward this link to any fellows you know and encourage them to join immediately:

IASLC Committees 2011 – 2012

Award Peter Goldstraw
Bylaw George Simon
Communications Heather Wakelee
Education Primo Lara
Ethics Kwun Fong
Fellowship Phil Mack
Finance  Fred R. Hirsch
Membership Nise Yamaguchi
Nominations Kathy Albain
Pathology Ming Tsao
Prevention, Screening & Early Detection John Field
Publications Glenwood Goss
Staging Ramon Rami-Porta
Advocates New TBD
Career Development New TBD
Nurses & Allied Professionals New TBD

















AACR IASLC Joint Conference – January 8-11, 2012

 aacr 2012

For further information: or


3rd ELCC (ESMO/IASLC) Lung Cancer Conference,
April 18 – 21, 2012, Geneva, Switzerland

 ELCC 2012

Abstracts deadline – January 11, 2012
For more information

5th Latin American Conference on Lung Cancer

 lalca 2012

The 5th Latin American Conference is now under planning and both an exciting educational – and scientific program have been developed, including sessions on the new staging, lung cancer screening and molecular testing for personalized medicine. Abstract deadline is March 30, 2012. For more information or

IASLC Web-based Education Programs

IASLC has introduced new educational programs on its Web site ( for its members and for healthcare professionals who are managing patients with lung cancer. The first program titled, “New Developments in Non-Small Cell Lung Cancer” features Professor Peter Goldstraw, MD, in a two-part presentation, that reviews the fundamentals of the new lung cancer staging system and examines the role of the TNM staging system of patients with small-cell lung cancer. The new, updated IASLC nodal staging map is also reviewed. In another presentation, Paul Bunn, Jr, MD, addresses the incorporation of molecular testing into the standard diagnostic workup of patients with NSCLC, and the selection of appropriate treatment for patients. The program concludes with case-study presentations by Drs. Bunn and Harvey I. Pass, illustrating the use of the new staging system and molecular testing.

Upcoming webinars include: “Clinical Implications of the New Adenocarcinoma Classification”

IASLC Staging Manual:

The IASLC Staging Manual and Handbook in Thoracic Oncologic has now surpassed 35,000 copies sold worldwide. In addition, the Staging Posters and Reference Cards continue to be popular reference aids of the 7th edition staging system for practitioners and tumor boards. IASLC members can continue to order these publications and products at special member pricing (; contact for further information).

In addition, translations of these publications have been completed or are in process in multiple languages: Chinese, Italian, Japanese, Polish, and Turkish. Discussions about future translations in Spanish, Arabic, and Russian are ongoing.

Staging Manual

iPhone/iPAD Staging Atlas

The new IASLC Staging Manual has been published in different formats. Several years of work from the IASLC Staging Committee and particularly the chair Dr. Peter Goldstraw, has resulted in a formal staging manual. The book and the “pocket-cards” can be ordered at

JTO Mobile options

JTO is available for your iPhone, Blackberry, or Android phone, in a view designed for easy reading on a small screen. Type into your phone’s browser to access the site. You can view current issue table of contents, most viewed articles, most emailed articles, or search across issues. If you have created a user name and password on the desktop version of, you can use that same log in information to view full text articles, complete with illustrations.

IASLC Textbook – Editor in Chief:
Harvey I. Pass, MD

Lung Cancer Book

Lung Cancer Book from Lippincott: The Fourth Edition of Principles and Practice of Lung Cancer, edited by Harvey I. Pass, MD et al is now available. For more information about the 1040 page book, with 330 illustrations (ISBN-10:0-7817-7365-2) or




Kristal Griffith - IASLC Director of Communications. Before joining the IASLC in December, 2011, Kristal was a News and Public Affairs Specialist and Video Coordinator for the University of Denver. Prior to her career in public relations, she was a reporter, winning an Edward R. Murrow Award in 2003 for her work in investigative reporting. She is the IASLC staff liaison for the following committees: Communications; Staging; and Early Detection, Screening and Prevention.


LUNGevity Foundation announces the issuance of its 2012 RFA for its Career Development Awards for Translational Research. Research projects are restricted to translational lung cancer research. The award will be open to junior faculty members who are within the first five years of their faculty appointment. Career Development Awards may be for a maximum of $100,000 per year for three years. with the possibility of reapplying at the end of the term for an additional two years. The RFA will be posted by Monday, November 21, at and on proposalCentral at For more information, contact Margery Jacobson at or 312-464-0716.

Upcoming IASLC Workshops/Meetings 2012- 2015

AACR-IASLC Joint Conference: Lung Cancer
January 8-12, 2012
Location: San Diego, California, U.S.A.

Thoracic Malignancy Conference
January 14-16, 2012

12th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting
February 22-25, 2012
Location: Santa Monica, California, U.S.A.

3rd European Lung Cancer Conference
April 18 - 21, 2012
Location: Geneva, Switzerland
More information:

5th Latin American Lung Cancer Conference
July 25-27, 2012
Location: Rio de Janeiro, Brazil
More information:

Chicago Multidisciplinary Symposium in Thoracic Oncology
September 6-8, 2012
Location: Hotel Marriott, Chicago, Illinois, U.S.A.
More information:

5th Asia Pacific Lung Cancer Conference
November 26-28, 2012
Location: Hilton Sea Hawk, Fukuoka, Japan
More information:

15th World Conference on Lung Cancer
October 27-31, 2013
Location: Sydney, Australia
More information:

16th World Conference on Lung Cancer
September 4-8, 2015
Location: Denver, Colorado, USA
More information: